Cases & Deals

  • Home
  • Practices
  • Bayer CropScience acquires U.S. agricultural biotech company Athenix for $400 million

Share

Bayer CropScience acquires U.S. agricultural biotech company Athenix for $400 million

November 2009

Client(s) Bayer AG

Jones Day advised Bayer CropScience LLC in its $400 million acquisition of Athenix Corp. The crop science industry has in recent years changed its focus from one centered on chemicals to one using biotechnology to develop crops that are herbicide, insect and nematode resistant. Athenix has an extensive microbial collection from which it has isolated herbicide tolerant genes, Bt insecticidal genes and genes with toxicity to nematodes. Athenix researchers develop and conduct bioassays to screen the microbial collection against the major insect pests of corn, cotton, and soybeans. Intersouth Partners, Polaris Venture Partners, Boston Millenia Partners, Hunt BioVentures, Eastman Ventures and Finestere Partners were some of the investors in Athenix since its formation in 2000.

In addition to M&A representation, Jones Day provided antitrust, environmental, and intellectual property advice regarding this transaction.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.